The UFHCC recognizes that a common barrier to successful trial completion is inadequate resource allocation. As a steward of limited resources, the UFHCC Feasibility Group (FG) is responsible for reviewing or providing feedback on the non-scientific aspects of a study being considered. The goal is to assist PIs and DSGs in ensuring adequate institutional, financial, personnel and patient resources are available. The UFHCC FG provides this information as a required component of the UFHCC CRO-managed protocol development and as a consultant to other UFHCC investigators. The FG issues a recommendation of feasible or non-feasible for each study reviewed to supplement DSG decision making.
FG meets every first and third Tuesday of the month and submissions for review are due the week prior to the meeting date by 12:00 pm. Protocols and budget drafts should be submitted to Protocol_Activation@cancer.ufl.edu.
Feasibility Group Members
|Associate Director for Clinical Investigation||Thomas George, M.D., FACP|
|Associate Director for Medical Affairs||Merry-Jennifer Markham, M.D.|
|Associate Director for Administration||Robert Houlihan, DHA, MBA, FACHE, CCRP, CRA|
|Administrative Director||Alison Ivey, R.N., MS, OCN, CCRP|
|Assistant Director of Clinical Operations||Leslie Pettiford, R.N., MS, OCN, CCRC|
|Assistant Director of Clinical Research Admin & Compliance||TBD|
|Assistant Director of Project Management & Regulatory Affairs||Alisha Daniels, M.D., MHA, CCRC|
|Assistant Director for Clinical Research Administration and Compliance||Ashley Anderson, MBA, ACRP-CP|
Core Feasibility Group members represent voting members and are responsible for making recommendations on proposed trials. The complete membership listing of Feasibility Group Members is available in the FG Charter.
For information related to the Feasibility Group, please contact Alisha Daniels, research manager, at firstname.lastname@example.org or 352.294.8568.